Thema: US45175G2075
IMA, US45175G2075
entrepreneur-3972324_1920.jpg - Foto: THN
ImageneBio stock heads toward November 11 earnings report
ImageneBio stock is approaching its November 11 earnings report as investors track progress in its clinical-stage immunology pipeline. Olevaprubart remains the key program.
ad-hoc-news.de, heute 00:27 Uhr
IMA, US45175G2075
ImageneBio grants 90,775 units: ImageneBio stock sits 55.71 ...
H.C. Wainwright kept a USD 28.00 target on October 1, 2026. ImageneBio stock sits 55.71 percent below its high before November 11, 2026 results.
ad-hoc-news.de, 16.10.26 04:09 Uhr
IMA, US45175G2075
IMA stock gains after ImageneBio grants employee awards
